Timolol Maleate USP For Compounding (API)

Timolol Maleate USP for Compounding (API) is an active pharmaceutical ingredient used to formulate ophthalmic solutions and other medications for treating glaucoma and ocular hypertension. As a non-selective beta-blocker, it reduces intraocular pressure by decreasing the production of aqueous humor in the eye, helping prevent optic nerve damage and vision loss. Compounding pharmacists prepare customized doses tailored to specific patient needs, ensuring effective management of these conditions while minimizing side effects and maximizing therapeutic benefits.

Timolol Maleate USP is an active pharmaceutical ingredient (API) used in the treatment of various eye conditions, such as glaucoma and ocular hypertension. It belongs to a class of medications known as beta-blockers, which work by decreasing the production of fluid in the eye and decreasing the pressure within the eye.

Timolol Maleate USP is a synthetic compound that is similar in structure to the hormone epinephrine, but it has a more selective effect on beta receptors in the eye. It is classified as a non-selective beta-adrenergic blocker, meaning it blocks both beta-1 and beta-2 receptors.

The main pharmacological properties of Timolol Maleate USP include its ability to lower intraocular pressure (IOP) by reducing the production of aqueous humor and increasing aqueous outflow. It also has the potential to reduce the likelihood of optic nerve damage, which is a common complication of elevated IOP.

Timolol Maleate USP is typically administered as eye drops, and it is available in various formulations and strengths. It is usually used in combination with other eye medications for the treatment of glaucoma and other eye conditions.

CAS Number: 26921-17-5

Property: Light Sensitive